Silver Creek Pharmaceuticals is a biotechnology company, develops protein therapeutics to treat cardiovascular diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 6, 2018 | Series Unknown | $20M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
JP Morgan | — | Series Unknown |